ENZON PHARMACEUTICALS INC's ticker is and the CUSIP is 29390410. A total of 1 filers reported holding ENZON PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $54,000 | -31.6% | 115,380 | 0.0% | 0.00% | – |
| Q4 2015 | $79,000 | -68.4% | 115,380 | -50.0% | 0.00% | -100.0% |
| Q3 2015 | $250,000 | +81.2% | 230,760 | +100.0% | 0.00% | 0.0% |
| Q2 2015 | $138,000 | +13.1% | 115,380 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $122,000 | -3.2% | 115,380 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $126,000 | +0.8% | 115,380 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $125,000 | – | 115,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 148,948 | $298,000 | 0.00% |
| State of New Jersey Common Pension Fund A | 60,000 | $120,000 | 0.00% |
| DEUTSCHE BANK AG\ | 30,813 | $60,000 | 0.00% |